Champions Oncology Retains Hayden IR to Execute Comprehensive Investor Relations Program
HACKENSACK, N.J., Jan. 19, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it has retained Hayden IR, a premier national...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]lations-program-300393603.html
